Sugi Predict

Sugi Predict / Compounds / SCHEMBL698020

SCHEMBL698020

SCHEMBL698020

O=C(Cl)c1ccc2c(c1)C(=O)c1ccccc1C2=O

nearest known ligand 0.69

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ TTR P02766 4/20 0.69
▸ PTPRC P08575 3/20 0.61
▸ HTR7 P34969 1/20 0.56
▸ HTR2B P41595 1/20 0.56
▸ S100A4 P26447 1/20 0.55
▸ NPC1 O15118 4/20 0.53
▸ RAB9A P51151 4/20 0.53
▸ ALDH1A1 P00352 3/20 0.53
▸ L3MBTL1 Q9Y468 2/20 0.53
▸ GAA P10253 1/20 0.53
▸ BCL2 P10415 1/20 0.52
▸ MCL1 Q07820 1/20 0.52
▸ HPGD P15428 2/20 0.50
▸ ATM Q13315 1/20 0.49
▸ CTSL P07711 1/20 0.49
▸ PTPN13 Q12923 1/20 0.49
▸ ACE2 Q9BYF1 1/20 0.49
▸ SMN1; SMN2 Q16637 2/20 0.48
▸ TDP1 Q9NUW8 2/20 0.48
▸ ELANE P08246 1/20 0.48

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3300661 0.98 TTR (0.67) TTRPTPRCHTR7HTR2BS100A4
SCHEMBL7551130 0.94 PTPRC (0.65) TTRPTPRCHTR7HTR2BS100A4
SCHEMBL28397117 0.94 TTR (0.59) TTRPTPRCHTR7HTR2BS100A4
SCHEMBL28399814 0.94 TTR (0.59) TTRPTPRCHTR7HTR2BS100A4
SCHEMBL11733475 0.90 TTR (0.53) TTRPTPRCHTR7HTR2BS100A4
Anthraquinone SCHEMBL9879416 0.87 KMT2A (0.57) TTRPTPRCHTR7HTR2BS100A4
SCHEMBL6638005 0.85 PTPRC (0.57) TTRPTPRCHTR7HTR2BS100A4
SCHEMBL123492 0.82 TTR (1.00) TTRPTPRCHTR7HTR2BS100A4
SCHEMBL30610011 0.82 TTR (1.00) TTRPTPRCHTR7HTR2BS100A4
SCHEMBL7720069 0.82 TTR (0.71) TTRPTPRCHTR7HTR2BS100A4

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 140 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-114105896-A Pigment synergist and preparation method thereof, photoresist composition and optical filter 山东凯瑞尔光电科技有限公司 2022-03-01 — — CN claimed
CN-108003349-B Preparation method of supercritical carbon dioxide thickening agent of siloxane polymer for fracturing 中国石油大学(华东) 2020-09-15 — — CN claimed
CN-109502600-B Preparation method and application of anthraquinone mediator modified molecular sieve 天津城建大学 2020-05-12 — — CN claimed
CN-109502600-A A kind of preparation method and applications of the mediator modified molecular sieve of anthraquinone 天津城建大学 2019-03-22 — — CN claimed
CN-108003349-A A kind of preparation method of pressure break siloxane polymer supercritical carbon dioxide thickener 中国石油大学(华东) 2018-05-08 — — CN claimed
CN-104788333-A 2-substituted-9,10-anthraquinone compounds, and preparation method and application thereof UNIV CHINA MEDICAL 2015-07-22 — — CN claimed
JP-4308558-A — — None — — JP disclosed
US-12466869-B2 Targeting of multiple antigens with multiplex CAR T cells in solid and liquid malignancies DANA-FARBER CANCER INSTITUTE, INC. (US) 2025-11-11 — — US disclosed
WO-2025095129-A1 CARBON DIOXIDE CAPTURE AND RELEASE DEVICE 国立大学法人横浜国立大学 2025-05-08 — — WO disclosed
US-20240316171-A1 COMPOSITIONS AND METHODS FOR TARGETED IMMUNOTHERAPY DANA FARBER CANCER INST INC (US) 2024-09-26 — — US disclosed
US-20240197884-A1 COMPOSITIONS AND METHODS FOR TARGETED TUMOR IMMUNOTHERAPY DANA FARBER CANCER INST INC (US) 2024-06-20 — — US disclosed
CN-114105896-A Pigment synergist and preparation method thereof, photoresist composition and optical filter 山东凯瑞尔光电科技有限公司 2022-03-01 — — CN disclosed
CN-108976153-B Antibacterial hydrophilic compound and application 海思美域(深圳)科技有限公司 2022-01-11 — — CN disclosed
EP-0374838-A2 Electrophotographic elements containing certain anthraquinone derivatives as electron-transport agents EASTMAN KODAK COMPANY (US) 1990-06-27 — — EP disclosed
US-4913996-A Electrophotographic elements containing certain anthraquinone derivatives as electron-transport agents EASTMAN KODAK COMPANY (US) 1990-04-03 — — US disclosed
EP-0331477-A2 Organic dye thin film and organic thin film element KABUSHIKI KAISHA TOSHIBA (JP) 1989-09-06 — — EP disclosed
US-4797347-A Process for producing electrically conductive coating CIBA-GEIGY CORPORATION (US) 1989-01-10 — — US disclosed
US-4677155-A Anthroquinonyl photosensitive polymers CIBA-GEIGY CORPORATION (US) 1987-06-30 — — US disclosed
US-4329456-A ACYLATION WITHOUT INTERMEDIATE ISOLATION CIBA-GEIGY AG (CH) 1982-05-11 — — US disclosed
US-4265633-A Process for the manufacture of vat dyes CIBA-GEIGY AG (CH) 1981-05-05 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-12466869-B2 Targeting of multiple antigens with multiplex CAR T cells in solid and liquid malignancies CD47, CD2, TP53 TTR 1284/4885PTPRC 99/4885HTR7 4821/4885
US-20240197884-A1 COMPOSITIONS AND METHODS FOR TARGETED TUMOR IMMUNOTHERAPY CD47, CD274, CD2 TTR 1625/4885PTPRC 74/4885HTR7 4756/4885
US-20240316171-A1 COMPOSITIONS AND METHODS FOR TARGETED IMMUNOTHERAPY TP53, CD47, MSH2 TTR 1491/4885PTPRC 35/4885HTR7 4615/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.